Skip to content

ICYMI: Senator Hassan’s Bipartisan Opioid Addiction Risk Transparency Act Signed Into Law as Part of FDA Bill

FDA Bill Also Includes Over-the-Counter Hearing Aid Act that Senator Hassan Helped Introduce

WASHINGTON – Last week, President Trump signed the Food and Drug Administration Reauthorization Act of 2017 into law, which included two measures championed by Senator Maggie Hassan.

The FDA Reauthorization bill included the bipartisan Opioid Addiction Risk Transparency Act, which Senator Hassan authored with Senator Todd Young (R-IN), and takes important steps to help ensure that doctors understand that all opioids – even ones that are called “abuse-deterrent” – are addictive.

The FDA bill also included the bipartisan Over-the-Counter Hearing Aid Act of 2017, which would make certain types of hearing aids available over the counter to Granite Staters and Americans with mild to moderate hearing impairment. Senator Hassan introduced the legislation with Senators Elizabeth Warren (D-MA), Chuck Grassley (R-IA), and Johnny Isakson (R-GA).